does bupropion take quit rates from about 5% to about 20% for smoking and vaping?
“it moves that number of 5% success rate to about what one sees with the clinical hypnosis to about 20% of people will successfully overcome their nicotine or I should say their smoking or vaping addiction.”
a host said on Huberman Lab, 2026-11-19, at 29:43. hear it in context → the speaker cited: Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice (2020).
first, the part that holds
the 20% figure holds up. in the fda-reviewed trials of bupropion for quitting cigarettes, roughly one in five people on the drug were still continuously abstinent at six months to a year (19% at 26 weeks in one trial, 23% at 52 weeks in another).
what we found when we went and looked
the fda label for the smoking-cessation product puts bupropion at 19% continuous abstinence at 26 weeks in the dose-response trial and 23% at 52 weeks in the comparator trial, so "about 20%" matches. the "5%" comparison is the problem. in those trials the comparison group got a placebo plus counseling, and 8% to 13% of them quit, not 5%. the cochrane review of 50 trials and 18,577 people puts bupropion's added effect at 6 to 8 more quitters per 100 (rr 1.60). going from 5% to 20% would be a fourfold effect, and that framing credits the drug with what counseling and trial selection also contribute. no trial of bupropion for quitting vaping appears in the cochrane living review on vaping cessation, so the vaping half of the claim has no data behind it.
assertion by assertion
| assertion | verdict | what the record says |
|---|---|---|
| about 20% of people who use bupropion to quit smoking succeed | confirmed | fda label, section 14: continuous abstinence was 19% at week 26 on 300 mg a day in the dose-response trial, and 30% at 26 weeks and 23% at 52 weeks in the comparator trial. caveat: these were motivated, nondepressed smokers of 15 or more cigarettes a day who also got individual counseling, and the label says quit rates in an unselected population may be lower. [2] |
| about 5% of people quitting without help succeed | unverifiable | in this session we could not read a primary source that gives an unaided long-term quit rate. the commonly cited systematic review of self-quitters was blocked at the publisher, and the review the speaker named gives no 5% figure in the text we read. the only no-drug comparison we did read is the placebo-plus-counseling arm in the label trials: 11% to 13% at 26 weeks and 8% at 52 weeks. [1][2] |
| bupropion moves success from about 5% to about 20%, roughly a fourfold effect | overstated | cochrane (2023, 50 studies, 18,577 participants): bupropion vs placebo or no medication, rr 1.60 (95% ci 1.49 to 1.72), which works out to six to eight more people quitting for six months or longer per 100. the review the speaker named says bupropion 'nearly doubled' cessation rates compared with placebo. it does not say quadrupled. putting the drug arm next to an unaided baseline instead of a placebo arm credits the drug with what counseling and trial selection also contribute. [1][2][3] |
| the same success rate applies to quitting vaping | unverifiable | cochrane's living review on quitting vaping (published 25 november 2025, evidence to 1 july 2025) includes 15 studies. bupropion appears only as a candidate medicine, and none of the included trials tested it. varenicline is the only drug with a signal, and that evidence is low-certainty. the fda label covers quitting cigarettes only. [2][4] |
| clinical hypnosis yields about the same ~20% success rate | unverifiable | cochrane (2019) found 'no clear evidence that hypnotherapy is better than other approaches in helping people to stop smoking', with low to very low certainty. the review gives no pooled 20% success rate that could support the comparison. [5] |
both directions
for the speaker: the fda label's long-term numbers for bupropion, 19% at 26 weeks and 23% at 52 weeks, sit right on "about 20%". the benefit is real and rests on high-certainty evidence: cochrane pools 50 trials at rr 1.60. in one trial the comparison group was down to 8% at a year, so a low single-digit baseline for people trying with no support at all is plausible, even though we could not read a primary source for it in this session.
against: the 5%-to-20% framing sets the drug arm of a trial against an unaided baseline. the trials' own placebo-plus-counseling groups quit at 8% to 13%, so the share that belongs to the drug is about 6 to 8 people per 100, not 15. the review the speaker named describes bupropion as nearly doubling quit rates, not quadrupling them. it also reports that varenicline and combination nicotine replacement outperformed bupropion in later studies, and we found neither 5% nor 20% in the text we read. vaping is folded into the claim with no bupropion trial behind it. finally, the label says quit rates in an unselected population may be lower than the trial rates.
what this cannot say
the label trials are from the 1990s, used carbon-monoxide-verified abstinence with counseling, and enrolled heavy smokers without depression. real-world rates may differ. we could not open the full cochrane review or the primary paper on unaided quit rates (both were blocked at the publisher), so the 5% baseline is unconfirmed here, not refuted. we read the named 2020 review through an automated text extraction, not the typeset pdf. the vaping verdict reflects missing trials, not evidence that bupropion fails for vaping.
the medication pages behind this check
sources, each one fetched and read
- Pharmacological approach to smoking cessation: an updated review for daily clinical practice. High Blood Pressure & Cardiovascular Prevention, 2020;27:349-362. doi:10.1007/s40292-020-00396-9 What we read there: "Bupropion nearly doubled smoking cessation rates compared to placebo, and it was equally effective in men and women"; "treatments for smoking cessation doubled abstinence rates after 6 months compared to placebo"; "More than 75% of people who try to quit smoking by themselves relapse within the first week." No 5% or 20% figure found in the text we read. Fetched 2026-11-20 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC7309212
- US FDA, prescribing information for bupropion hydrochloride sustained-release tablets as an aid to smoking cessation, NDA 020711, revised 6/2016, section 14 clinical studies What we read there: Dose-response trial, abstinence week 4 through week 26: placebo 11%, 300 mg/day 19%. Comparator trial continuous abstinence: 30% vs 13% placebo at 26 weeks; 23% vs 8% placebo at 52 weeks. All arms received individual counseling. "Quit rates in an unselected population may be lower than the above rates." Fetched 2026-11-20 (HTTP 200). https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020711s044lbl.pdf
- Cochrane Database of Systematic Reviews, Antidepressants for smoking cessation, 2023, Issue 5, CD000031.pub6 (plain language summary) What we read there: Bupropion vs placebo or no pharmacological treatment: RR 1.60 (95% CI 1.49 to 1.72), 50 studies, 18,577 participants; six to eight more people successfully quitting for six months or more for every one hundred who try. Fetched 2026-11-20 (HTTP 200). https://www.cochrane.org/CD000031/TOBACCO_bupropion-for-smoking-cessation
- Cochrane Database of Systematic Reviews, Interventions for quitting vaping, CD016058, published 25 November 2025 (plain language summary) What we read there: 15 included studies tested combination NRT, NRT doses, cytisine, varenicline, reduction, text messaging, e-learning and incentives. Bupropion is named only as a medicine that could be used. "Varenicline may help more people stop vaping compared to placebo" (low-certainty). Fetched 2026-11-20 (HTTP 200). https://www.cochrane.org/evidence/CD016058_what-are-effects-treatments-help-people-stop-vaping-nicotine
- Cochrane Database of Systematic Reviews, Hypnotherapy for smoking cessation, 2019, Issue 6, CD001008 (plain language summary) What we read there: "There is no clear evidence that hypnotherapy is better than other approaches in helping people to stop smoking"; certainty low to very low. Fetched 2026-11-20 (HTTP 200). https://www.cochrane.org/CD001008/TOBACCO_does-hypnotherapy-help-people-who-are-trying-stop-smoking
speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam